DCTD Leadership Appointments Announced
NCI recently announced two appointments to top leadership positions within the Division of Cancer Treatment and Diagnosis (DCTD). Dr. Jeffrey Abrams was selected as associate director of the DCTD Cancer Therapy Evaluation Program (CTEP) and Dr. James Tatum was chosen as the associate director of the DCTD Cancer Imaging Program (CIP).

Dr. Abrams, who served as CTEP's acting associate director for the past year, joined DCTD in 1993 as a clinical research scientist to oversee the breast cancer treatment trials portfolio and conduct clinical trials at the NIH Clinical Center and the National Naval Medical Center.

Dr. Tatum joined CIP in 1998 as a special assistant to the associate director. In 2006, Dr. Tatum assumed leadership of CIP's Molecular Imaging Branch. Since July 2007, he has used his expertise in the areas of molecular imaging and imaging drug development to guide CIP as its acting associate director.

DCCPS Report Highlights 10 Years of Progress
NCI's Division of Cancer Control and Population Sciences (DCCPS) recently posted online 2007 Overview and Highlights, a report describing the institute's return on 10 years of investment in DCCPS since its creation in 1997.

The report highlights progress in research areas including epidemiology and genetics; cancer prevention and control; detection and diagnosis; tobacco control; diet, weight and physical activity; health communication; risk factor monitoring and prediction; quality of care and health services outcome; health disparities; cancer survivorship; surveillance; and research dissemination.

To order a free copy of the report, go to www.cancer.gov/publications or call NCI's Cancer Information Service at 1-800-4-CANCER (1-800-422-6237).